Related Experiment Videos
Antimycobacterial arylidenecyclohexanones and related Mannich bases
J R Dimmock1, N M Kandepu, U Das
1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada. dimmock@skyway.usask.ca
Die Pharmazie
|August 7, 2004
Summary
Mannich bases derived from 2-arylidenecyclohexanones show potent activity against Mycobacterium tuberculosis. These novel compounds offer a promising new class of antimycobacterials for treating tuberculosis.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Microbiology
Background:
- Tuberculosis remains a significant global health challenge, necessitating the development of new therapeutic agents.
- Existing treatments face challenges with drug resistance and side effects, driving the search for novel antimycobacterial compounds.
Purpose of the Study:
- To synthesize and evaluate 2-arylidenecyclohexanones and their Mannich bases for antimycobacterial activity against Mycobacterium tuberculosis H37Rv.
- To investigate the potential of these compounds as a novel class of antimycobacterials.
Main Methods:
- Synthesis of various 2-arylidenecyclohexanones, related Mannich bases, and 2,6-bis(arylidene)cyclohexanones.
- In vitro evaluation of synthesized compounds against Mycobacterium tuberculosis H37Rv at a concentration of 12.5 microg/ml.
- Assessment of activity against Mycobacterium avium for selected Mannich bases.
Main Results:
- Nearly half of the unsaturated ketones showed moderate inhibition (21-66%) of Mycobacterium tuberculosis growth.
- All evaluated Mannich bases achieved significant inhibition (≥99%) of Mycobacterium tuberculosis growth.
- Two Mannich bases exhibited notable potency against Mycobacterium avium.
Conclusions:
- Mannich bases of 2-arylidenecyclohexanones represent a promising novel class of antimycobacterial agents.
- Molecular properties like hydrophobicity and width may influence the bioactivity of these compounds.
- Further research into Mannich bases could lead to new treatments for mycobacterial infections.